NYSE - Delayed Quote USD
Boston Scientific Corporation (BSX)
106.04
+1.18
+(1.13%)
At close: May 16 at 4:00:02 PM EDT
105.50
-0.54
(-0.51%)
After hours: May 16 at 7:52:36 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 24 | 24 | 31 | 31 |
| Avg. Estimate | 0.72 | 0.7 | 2.92 | 3.29 |
| Low Estimate | 0.71 | 0.67 | 2.87 | 3.17 |
| High Estimate | 0.76 | 0.74 | 2.98 | 3.51 |
| Year Ago EPS | 0.62 | 0.63 | 2.51 | 2.92 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 23 | 22 | 31 | 31 |
| Avg. Estimate | 4.89B | 4.86B | 19.48B | 21.53B |
| Low Estimate | 4.85B | 4.8B | 19.02B | 20.57B |
| High Estimate | 4.99B | 4.94B | 19.78B | 21.98B |
| Year Ago Sales | 4.12B | 4.21B | 16.75B | 19.48B |
| Sales Growth (year/est) | 18.78% | 15.55% | 16.34% | 10.49% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.58 | 0.59 | 0.66 | 0.67 |
| EPS Actual | 0.62 | 0.63 | 0.7 | 0.75 |
| Difference | 0.04 | 0.04 | 0.04 | 0.08 |
| Surprise % | 6.51% | 7.05% | 6.57% | 11.52% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.72 | 0.7 | 2.92 | 3.29 |
| 7 Days Ago | 0.72 | 0.7 | 2.92 | 3.29 |
| 30 Days Ago | 0.71 | 0.71 | 2.86 | 3.26 |
| 60 Days Ago | 0.71 | 0.71 | 2.86 | 3.26 |
| 90 Days Ago | 0.71 | 0.71 | 2.85 | 3.26 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 21 | -- | 1 | 2 |
| Up Last 30 Days | 21 | -- | 27 | 20 |
| Down Last 7 Days | 1 | 19 | -- | -- |
| Down Last 30 Days | -- | 19 | 1 | 7 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BSX | 16.81% | 11.07% | 16.17% | 12.86% |
| S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 5/16/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/25/2025 |
| Maintains | Needham: Buy to Buy | 4/24/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 4/24/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/24/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 4/24/2025 |
Related Tickers
MDT Medtronic plc
86.44
+0.38%
PEN Penumbra, Inc.
280.68
+1.95%
SYK Stryker Corporation
394.21
+0.51%
ABT Abbott Laboratories
134.80
+1.09%
DXCM DexCom, Inc.
85.48
-0.22%
EW Edwards Lifesciences Corporation
78.00
+1.46%
PODD Insulet Corporation
324.75
+0.85%
ITGR Integer Holdings Corporation
120.99
+1.61%
ZBH Zimmer Biomet Holdings, Inc.
96.95
+0.23%
TMDX TransMedics Group, Inc.
121.58
-0.19%